Short-chain fatty acids regulate IGF-binding protein secretion by intestinal epithelial cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 275, Issue 1 38-1, 1998, Pages

  Nishimura, Akiyoshi ^a   Fujimoto, Mika ^a,b   Oguchi, Satoshi ^a   Fusunyan, Robert D ^a   MacDermott, Richard P ^b   Sanderson, Ian R ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Acetate; Butyrate; Caco 2 cells; Histone acetylation; Polarity; Propionate

Indexed keywords

ACETIC ACID; BUTYRIC ACID; HISTONE; PROPIONIC ACID; SHORT CHAIN FATTY ACID; SOMATOMEDIN BINDING PROTEIN;

ACETYLATION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELECTION; CHROMOSOMAL LOCALIZATION; DRUG RECEPTOR BINDING; EPITHELIUM CELL; FATTY ACID METABOLISM; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION;

EID: 0031858569     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.275.1.e55     Document Type: Article

References (50)

1. Albiston, A. L., R. G. Taylor, A. C. Herington, D. J. Beveridge, and P. J. Fuller. Divergent ileal IGF-I and IGFBP-3 gene expression after small bowel resection: a novel mechanism to amplify IGF action? Mol. Cell. Endocrinol. 83: R17-R20, 1992.
2. Allander, S. V., S. Bajalica, C. Larsson, H. Luthman, D. R. Powell, I. Stern, G. Weber, H. Zazzi, and E. Ehrenborg. Structure and chromosomal localization of human insulin-like growth factor-binding protein genes. Growth Regul. 3: 3-5, 1993.
3. Arts, J., M. Lansink, J. Grimbergen, K. H. Toet, and T. Kooistra. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem. J. 310: 171-176, 1995.
4. Bang, P., K. Brismar, and R. G. Rosenfeld. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J. Clin. Endocrinol. Metab. 78: 1119-1127, 1994.
5. Binkert, C., J. Landwehr, J.-L. Marry, J. Schwander, and G. Heinrich. Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMB;O J. 8: 2497-2502, 1989.
6. Blum, W. F., E. W. Jenne, F. Reppin, K. Kietzmann, M. B. Ranke, and J. R. Bierich. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 125: 766-772, 1989.
7. Brewer, M. T., G. L. Stetler, C. H. Squires, R. C. Thompson, W. H. Busby, and D. R. Clemmons. Cloning, characterization, and expression of human insulin-like growth factor binding protein. Biochem. Biophys. Res. Commun. 152: 1289-1297, 1988.
8. Bry, L., P. G. Falk, T. Midtvedt, and J. I. Gordon. A model of host-microbial interactions in an open mammalian ecosystem. Science 273: 1380-1383, 1996.
9. Candido, E. P. M., R. Reeves, and J. R. Davie. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14: 105-113, 1978.
10. Chung, Y. S., I. S. Song, R. H. Erickson, M. H. Sleisenger, and Y. S. Kim. Effect of sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res. 45: 2976-2982, 1985.
11. Clark, R., J. Strasser, S. McCabe, K. Robbins, and P. Jardieu. Insulin-like growth factor stimulation of lymphocytes. J. Clin. Invest. 92: 540-548, 1993.
12. Clemmons, D. R., M. L. Dehoff, W. H. Busby, M. L. Bayne, and M. A. Cascieri. Competition for binding to insulin-like growth factor (IGF) binding protein-2,3,4, and 5 by the IGFs and IGF analogs. Endocrinology 131: 890-895, 1992.
13. Cousens, L. S., and B. M. Alberts. Accessibility of newly synthesized chromatin to histone acetylase. J. Biol. Chem. 257: 3945-3949, 1982.
14. Cubbage, M. L., A. Suwanichkul, and D. R. Powell. Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activity. J. Biol. Chem. 265: 12642-12649, 1990.
15. Cummings, J. H., and H. N. Englyst. Fermentation in the human large intestine and the available substrates. Am. J. Clin. Nutr. 45: 1243-1255, 1987.
16. Cummings, J. H., and G. T. MacFarlane. The control and consequences of bacterial fermentation in the human colon. J. Appl. Bacteriol. 70: 443-459, 1991.
17. Dahlqvist, A. Assay of intestinal disaccharidase. Anal. Biochem. 22: 99-107, 1968.
18. Davenport, M. L., D. R. Clemmons, M. W. Miles, C. Camacho-Hubner, A. J. D'Ercole, and L. E. Underwood. Regulation of serum insulin-like growth factor I (IGF-I) and IGF binding proteins in rat pregnancy. Endocrinology 127: 1278-1286, 1990.
19. De Mellow, J. S. M., and R. Baxter. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun. 156: 199-204, 1988.
20. Gum, J. R., W. K. Kam, J. C. Byrd, J. W. Hicks, M. H. Sleisenger, and Y. S. Kim. Effects of sodium butyrate on human colonic adenocarcinoma cells. J. Biol. Chem. 262: 1092-1097, 1987.
21. Guo, Y.-S., R. D. Beauchamp, G.-F. Jin, C. M. Townsend, and J. C. Thompson. Insulin-like growth factor-binding protein modulates the growth response to insulin-like growth factor 1 by human gastric cancer cells. Gastroenterology 104: 1595-1604, 1993.
22. Hossenlopp, P., D. Seurin, B. Segovia-Quinson, S. Hardouin, and M. Binoux. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154: 138-143, 1986.
23. Humbel, R. E. Insulin-like growth factors I and II. Eur. J. Biochem. 190: 445-462, 1990.
24. Johnson, L. R., and S. A. McCormack. Regulation of gastrointestinal mucosal growth. In: Physiology of the Gastrointestinal Tract (3rd ed.), edited by L. R. Johnson. New York: Raven, 1994, p. 611-633.
25. Laburthe, M., C. Rouyer-Fessard, and S. Gammeltoft. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. Am. J. Physiol. 254 (Gastrointest. Liver Physiol. 17): G457-G462, 1988.
26. Nowak, R. Molecular machines may aid gene expression. Science 270: 1589-1590, 1995.
27. Oguchi, S., W. A. Walker, and I. R. Sanderson. Insulin-like growth factor binding protein profile secreted by human intestinal epithelial cells varies with polarity. Biochem. Biophys. Res. Commun. 196: 789-793, 1993.
28. Oguchi, S., W. A. Walker, and I. R. Sanderson. Profile of IGF-binding proteins secreted by intestinal epithelial cells changes with differentiation. Am. J. Physiol. 267 (Gastrointest. Liver Physiol. 30): G843-G850, 1994.
29. Oguchi, S., W. A. Walker, and I. R. Sanderson. Differentiation and polarity alter the binding of IGF-I to human intestinal epithelial (Caco-2) cells. J. Pediatr. Gastroenterol. Nutr. 20: 148-155, 1995.
30. Oh, Y., H. L. Müller, D.-Y. Lee, P. J. Fielder, and R. G. Rosenfeld. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Endocrinology 132: 1337-1344, 1993.
31. Ohno, Y., J. Lee, R. D. Fusunyan, R. P. MacDermott, and I. R. Sanderson. Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells. Proc. Natl. Acad. Sci. USA 94: 10279-10286, 1997.
32. Park, J. H. Y., R. H. McCusker, J. A. Vanderhoof, H. Mohammadpour, R. F. Harty, and R. G. MacDonald. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation. Endocrinology 131: 1359-1368, 1992.
33. Park, J. H. Y., J. A. Vanderhoof, D. Blackwood, and R. G. MacDonald. Characterization of type I and type II insulin-like growth factor receptors in an intestinal epithelial cell line. Endocrinology 126: 2998-3005, 1990.
34. Pinto, M., S. Robine-Leon, M.-D. Appay, M. Kedinger, N. Triadou, E. Dussaulx, B. Lacroix, P. Simon-Assmann, K. Haffen, J. Fogh, and A. Zweibaum. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell 47: 323-330, 1983.
35. Rath, H. C., H. H. Herfarth, J. S. Ikeda, W. B. Grenther, T. E. Hamm, E. Balish, J. D. Taurog, R. E. Hammer, K. H. Wilson, and R. B. Sartor. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta 2 microglobulin transgenic rats. J. Clin. Invest. 98: 945-953, 1996.
36. Remacle-Bonnet, M., F. Garrouste, F. E. Atiq, J. Marvaldi, and G. Pommier. Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. J. Clin. Invest. 96: 192-200, 1995.
37. Riggs, M. G., R. G. Whittaker, J. R. Neumann, and V. M. Ingram. n-Butyrate causes histone modification in HeLa and friend erythroleukaemia cells. Nature 268: 462-464, 1977.
38. Roediger, W. E. W. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83: 424-429, 1982.
39. Rouyer-Fessard, C., S. Gammeltoft, and M. Laburthe. Expression of two types of receptor for insulin-like growth factors in human colonic epithelium. Gastroenterology 98: 703-707, 1990.
40. Royall, D., B. M. Wolever, and K. N. Jeejeebhoy. Clinical significance of colonic fermentation. Am. J. Gastroenterol. 85: 1307-1312, 1990.
41. Sanderson, I. R., L. A. Brueton, P. Boulton, I. Menzies, and J. A. Walker-Smith. Improvement of abnormal lactulose/ rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut 28: 1073-1076, 1987.
42. Shimasaki, S., and N. Ling. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res. 3: 243-266, 1991.
43. Shimasaki, S., M. Shimonaka, H.-P. Zhang, and N. Ling. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human serum. J. Biol. Chem. 266: 10646-10653, 1991.
44. Souleimani, A., and C. Asselin. Regulation of C-fos expression by sodium butyrate in the human colon carcinoma cell line Caco-2. Biochem. Biophys. Res. Commun. 193: 330-336, 1993.
45. Straus, D. S. Nutritional regulation of hormones and growth factors that control mammalian growth. FASEB J. 8: 6-12, 1994.
46. Tapson, V. F., M. Boni-Schnetzler, P. F. Pilch, D. M. Center, and J. S. Berman. Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro. J. Clin. Invest. 82: 950-957, 1988.
47. Termanini, B., R. V. Nardi, T. M. Finan, I. Parikh, and L. Y. Korman. Insulin-like growth factor I receptors in rabbit gastrointestinal tract. Characterization and autoradiographic localization. Gastroenterology 99: 51-60, 1990.
48. Whitehead, R. H., G. P. Young, and P. S. Bhathal. Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut 27: 1457-1463, 1986.
49. Yoshida, M., M. Kijima, M. Akita, and T. Beppu. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265: 17174-17179, 1990.
50. Zarrilli, R., M. Romano, S. Pignata, S. Casola, C. B. Bruni, and A. M. Acquaviva. Constitutive insulin-like growth factor-II expression interferes with the enterocyte-like differentiation of CaCo-2 cells. J. Biol. Chem. 271: 8108-8114, 1996.